comprehensive -WSS

comprehensive

author：fashion 2025-10-06 11:41:28 - browse：3163

U.S. legislation that would sever ties with Chinese drugmakers would jeopardize the drug supply for millions of American patients if it’s passed, the biotechnology industry’s main trade group has told Congress.

Congress is considering legislation, called the BIOSECURE Act, that would make it difficult for Chinese contract development and manufacturing organizations to do business with biotechnology companies that work with the U.S. federal government. Biotechs hire Chinese CDMOs, as they’re often called, for services that include product manufacturing, development, formulation, packaging, and distribution.

The BIOSECURE Act would stop the federal government from contracting with, or providing grants to, companies that do business with so-called Chinese “companies of concern.” The impact of the legislation would depend in large part on who is in the White House. The White House’s Office of Management and Budget would determine which companies are blacklisted, but a handful of specific companies would automatically go on that list, including the biotech giant WuXi AppTec.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Stanford president's case begs question: Who takes blame?

leisure time

WSS

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

DeSantis talks Trump, trans issues and 'what wokeness is'

Fauci's latest grilling in Congress: 9 hours, behind closed doors

A preacher's new calling: Diversifying neuroscience research

Senate committee advances SCOTUS ethics bill after alleged justice misconduct

Hospital chaplains balance Covid safety with patients’ spiritual needs

focus

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

knowledge

Guidelines to prevent youth baseball injuries need more muscle

EF3 tornado rips through North Carolina amid extreme weather nationwide

How one medical school became remarkably diverse

Study suggests new cause of Down syndrome: cells linked to aging

New air purifier tech could be key to improving indoor air quality

Medicare Advantage overpayments discussion gets experts fired up

George Santos makes 1st court appearance after pleading not guilty to 13 counts

FDA early review: GLP

United colonoscopy coverage change 'may cost lives,' doctors say

DeSantis talks Trump, trans issues and 'what wokeness is'

entertainment

Medicare Advantage coverage denials need scrutiny, senators say

Judge rejects Trump's request to move Stormy Daniels hush

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

American taxpayers paid $1.8 trillion in health care costs in 2022

Divers poised to search for children washed away in Pennsylvania flash flood

Mass General totes up its waste in a move to tackle climate change

focus

leisure time

entertainment

hotspot